These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 31992505)

  • 1. Importance of cardiac magnetic resonance findings in the diagnosis of left dominant arrythmogenic cardiomyopathy.
    Feliu E; Moscicki R; Carrillo L; García-Fernández A; Martínez Martínez JG; Ruiz-Nodar JM
    Rev Esp Cardiol (Engl Ed); 2020 Nov; 73(11):885-892. PubMed ID: 31992505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.
    Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M
    Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study.
    Pöyhönen P; Kivistö S; Holmström M; Hänninen H
    BMC Cardiovasc Disord; 2014 Aug; 14():110. PubMed ID: 25160650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic expression in hypertrophic cardiomyopathy and late gadolinium enhancement on cardiac magnetic resonance.
    Caetano F; Botelho A; Trigo J; Silva J; Almeida I; Venâncio M; Pais J; Sanches C; Leitão Marques A
    Rev Port Cardiol; 2014 May; 33(5):261-7. PubMed ID: 24909443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac magnetic resonance features of left dominant arrhythmogenic cardiomyopathy: differential diagnosis with myocarditis.
    Andreini D; Conte E; Casella M; Mushtaq S; Pontone G; Dello Russo A; Nicoli F; Carità P; Catto V; Vettor G; Gasperetti A; Sommariva E; Rizzo S; Basso C; Tondo C; Pepi M
    Int J Cardiovasc Imaging; 2022 Feb; 38(2):397-405. PubMed ID: 34546457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity.
    Sen-Chowdhry S; Syrris P; Prasad SK; Hughes SE; Merrifield R; Ward D; Pennell DJ; McKenna WJ
    J Am Coll Cardiol; 2008 Dec; 52(25):2175-87. PubMed ID: 19095136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern of late gadolinium enhancement predicts arrhythmic events in patients with non-ischemic cardiomyopathy.
    Shin DG; Lee HJ; Park J; Uhm JS; Pak HN; Lee MH; Kim YJ; Joung B
    Int J Cardiol; 2016 Nov; 222():9-15. PubMed ID: 27458824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis.
    Kuruvilla S; Adenaw N; Katwal AB; Lipinski MJ; Kramer CM; Salerno M
    Circ Cardiovasc Imaging; 2014 Mar; 7(2):250-258. PubMed ID: 24363358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sudden Cardiac Death Risk Prediction: The Role of Cardiac Magnetic Resonance Imaging.
    van der Bijl P; Podlesnikar T; Bax JJ; Delgado V
    Rev Esp Cardiol (Engl Ed); 2018 Nov; 71(11):961-970. PubMed ID: 29970349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and Prognosis in Sudden Cardiac Arrest Survivors Without Coronary Artery Disease: Utility of a Clinical Approach Using Cardiac Magnetic Resonance Imaging.
    Rodrigues P; Joshi A; Williams H; Westwood M; Petersen SE; Zemrak F; Schilling RJ; Kirkby C; Wragg A; Manisty C; Mohiddin S
    Circ Cardiovasc Imaging; 2017 Dec; 10(12):e006709. PubMed ID: 29237609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Late Gadolinium Enhancement Detected on Cardiac Magnetic Resonance in Cardiac Sarcoidosis.
    Stevenson A; Bray JJH; Tregidgo L; Ahmad M; Sharma A; Ng A; Siddiqui A; Khalid AA; Hylton K; Ionescu A; Providencia R; Kirresh A
    JACC Cardiovasc Imaging; 2023 Mar; 16(3):345-357. PubMed ID: 36752432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of ventricular arrhythmias using cardiovascular magnetic resonance.
    Mavrogeni S; Petrou E; Kolovou G; Theodorakis G; Iliodromitis E
    Eur Heart J Cardiovasc Imaging; 2013 Jun; 14(6):518-25. PubMed ID: 23324829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Arrhythmogenic cardiomyopathy. Patterns of ventricular involvement using cardiac magnetic resonance].
    Igual B; Zorio E; Maceira A; Estornell J; Lopez-Lereu MP; Monmeneu JV; Quesada A; Navarro J; Mas F; Salvador A
    Rev Esp Cardiol; 2011 Dec; 64(12):1114-22. PubMed ID: 22030343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Combined Incremental Prognostic Value of LVEF, Late Gadolinium Enhancement, and Global Circumferential Strain Assessed by CMR.
    Mordi I; Bezerra H; Carrick D; Tzemos N
    JACC Cardiovasc Imaging; 2015 May; 8(5):540-549. PubMed ID: 25890580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cardiac magnetic resonance in the differential diagnosis between arrhythmogenic cardiomyopathy with left ventricular involvement and previous infectious myocarditis.
    Colombo D; Turco A; Lomi S; Valentini A; Bassi E; Scelsi L; Greco A; Schirinzi S; Zacchino M; Acquaro M; Oliveri F; Preda L; Ghio S
    Int J Cardiol; 2023 Mar; 374():120-126. PubMed ID: 36535562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial Fibrosis as a Predictor of Ventricular Arrhythmias in Patients With Non-ischemic Cardiomyopathy.
    Schiau C; Leucuța DC; Dudea SM; Manole S
    In Vivo; 2021; 35(3):1677-1685. PubMed ID: 33910852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical presentations leading to arrhythmogenic left ventricular cardiomyopathy.
    Graziosi M; Ditaranto R; Rapezzi C; Pasquale F; Lovato L; Leone O; Parisi V; Potena L; Ferrara V; Minnucci M; Caponetti AG; Chiti C; Ferlini A; Gualandi F; Rossi C; Berardini A; Tini G; Bertini M; Ziacchi M; Biffi M; Galie N; Olivotto I; Biagini E
    Open Heart; 2022 Apr; 9(1):. PubMed ID: 35444050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The extent of late gadolinium enhancement predicts mortality, sudden death and major adverse cardiovascular events in patients with nonischaemic cardiomyopathy: a systematic review and meta-analysis.
    Golukhova EZ; Bulaeva NI; Alexandrova SA; Mrikaev DV; Gromova OI; Ruzina EV; Berdibekov BS
    Clin Radiol; 2023 Apr; 78(4):e342-e349. PubMed ID: 36707397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy.
    Wu KC; Weiss RG; Thiemann DR; Kitagawa K; Schmidt A; Dalal D; Lai S; Bluemke DA; Gerstenblith G; Marbán E; Tomaselli GF; Lima JA
    J Am Coll Cardiol; 2008 Jun; 51(25):2414-21. PubMed ID: 18565399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy.
    Perazzolo Marra M; De Lazzari M; Zorzi A; Migliore F; Zilio F; Calore C; Vettor G; Tona F; Tarantini G; Cacciavillani L; Corbetti F; Giorgi B; Miotto D; Thiene G; Basso C; Iliceto S; Corrado D
    Heart Rhythm; 2014 May; 11(5):856-63. PubMed ID: 24440822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.